BOTHE Bone Therapeutics SA

Bone Therapeutics, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia

Bone Therapeutics, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia
EN
05/10/2020

Underlying

BOTHEBone Therapeutics SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bone Therapeutics SA

 PRESS RELEASE
Free
BOTHE Bone Therapeuti...

BioSenic provides third quarter 2024 Business Update

BioSenic provides third quarter 2024 Business Update BioSenic provides third quarter 2024 Business Update BioSenic is actively seeking one or more new assets through a merger or acquisition process Mont-Saint-Guibert, Belgium, October 28, 2024, 7.00 am CEST – Regulated Information - (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases, as well as cell repair, today provides its business update for the third quarter, ended 30 September 2024. Key highlights In July 2024, BioSenic sig...

October 28, 2024 1 EN
 PRESS RELEASE
Free
BOTHE Bone Therapeuti...

BioSenic fait le point sur ses activités du troisième trimestre 2024

BioSenic fait le point sur ses activités du troisième trimestre 2024 BioSenic fait le point sur ses activités du troisième trimestre 2024 BioSenic lance activement la recherche d'un ou de plusieurs nouveaux actifs par le biais d'un processus de fusion ou d'acquisition Mont-Saint-Guibert, Belgique, le 28 octobre 2024 à 07h00 CEST – Information Reglementée -  Euronext Bruxelles et Paris : BIOS), la société en phase clinique spécialisée dans les maladies auto-immunes et inflammatoires sévères, ainsi que la réparation cellulaire, fait aujourd’hui un point sur son activité pou...

October 28, 2024 1 EN
 PRESS RELEASE
Free
BOTHE Bone Therapeuti...

BioSenic S.A. : Transparency notification received from ABO Infiniu...

BioSenic S.A. : Transparency notification received from ABO Infinium Americas OpCo LTD. REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, October 7, 2024, 7:00 CEST – (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today announces that it has received a transparency notification from ABO Infinium Americas OpCo LTD. The details of the transparency notification are set out below and the full text of the transparency notificat...

October 7, 2024 1 EN
 PRESS RELEASE
Free
BOTHE Bone Therapeuti...

BioSenic S.A. : Notification de transparence reçue de la part de ABO...

BioSenic S.A. : Notification de transparence reçue de la part de ABO Infinium Americas OpCo LTD.  INFORMATION REGLEMENTEE Article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes Mont-Saint-Guibert, Belgique, le 7 octobre 2024 à 7h00 CEST – (Euronext Bruxelles et Paris: BIOS), société spécialisée en essais cliniques dans les maladies auto-immunes et inflammatoires graves et la thérapie cellulaire, annonce aujourd’hui la réception de la notification de transparence de ABO Infinium Americas OpCo LTD. Les détails de la notification de transparence sont rep...

October 7, 2024 1 EN
 PRESS RELEASE
Free
BOTHE Bone Therapeuti...

BioSenic announces that it has started to look for new assets, the sec...

BioSenic announces that it has started to look for new assets, the securing of its financing for the coming months by means of an amendment to its convertible bond contract, a change to the composition of its board of directors PRIVILEGED INFORMATION Biosenic and Global Tech Opportunities 15 ("GTO 15") have entered into an amendment to the convertible bonds ("CB") agreement securing a further EUR 1.5 million of the programme, including at least two tranches of EUR 0.2 million net each.François Rieger and Véronique Pomi-Schneiter resign from their positions as CEO, chairman and executi...

September 30, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch